<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Preoperative chemotherapy has become more common in the management of multiple resectable colorectal <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastases</z:e>; however, the benefit is unclear </plain></SENT>
<SENT sid="1" pm="."><plain>This study examined clinical outcomes following liver resection for multiple colorectal <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastases</z:e> with the surgery up-front approach </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Data collected prospectively over a 16-year period for 736 patients who underwent hepatic resection at two different centers were reviewed </plain></SENT>
<SENT sid="3" pm="."><plain>Patients were divided into three groups depending on the number of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> as follows: group A, between one and three <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> (n = 493); group B, between four and seven <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> (n = 141); and group C, eight or more <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> (n = 102) </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: The 5-year overall and recurrence-free survival rates were 51 and 21 %, respectively, for the entire patient cohort, 56 and 29 % in group A, 41 and 12 % in group B, and 33 and 1.7 % in group C </plain></SENT>
<SENT sid="5" pm="."><plain>Multivariate analysis showed that decreased survival was associated with positive lymph node <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> of the <z:e sem="disease" ids="C0677930" disease_type="Neoplastic Process" abbrv="">primary tumor</z:e>, the presence of extrahepatic <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e>, a maximum <z:e sem="disease" ids="C0023903" disease_type="Neoplastic Process" abbrv="">liver tumor</z:e> size &gt;5 cm, and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> exposure during liver resection </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSIONS: In patients with multiple <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastases</z:e>, the number of <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastases</z:e> has less impact on the prognosis than other prognostic factors </plain></SENT>
<SENT sid="7" pm="."><plain>Complete resection with repeat metastasectomy offers a chance of cure even in patients with numerous colorectal <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastases</z:e> (i.e., those with eight or more nodules) </plain></SENT>
<SENT sid="8" pm="."><plain>A further prospective study is necessary to clarify the optimal setting of preoperative chemotherapy </plain></SENT>
</text></document>